Literature DB >> 3923627

Increased levels of HDL-cholesterol and apolipoprotein A-I after intensified insulin therapy for diabetes.

D P Wilson, J D Fesmire, R K Endres, P R Blackett.   

Abstract

Sixteen subjects with insulin-dependent diabetes mellitus were studied to determine whether changes in plasma lipids and apolipoproteins follow intensified control using preprandial doses of regular insulin with an additional dose of NPH insulin before bedtime. The mean total dialy dose of insulin was increased from 1.03 +/- 0.09 to 1.17 +/- 0.44 units/kg throughout the six-month period. Levels of HDL-cholesterol and apolipoprotein A-I increased without significant changes in hemoglobin A1 (HbA1), triglyceride, or cholesterol. These findings suggest that increases in HDL-cholesterol and apolipoprotein A-I were a result of the intensified insulin delivery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923627     DOI: 10.1097/00007611-198506000-00004

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

1.  Insulin Pump Therapy - Influence on Body Fat Redistribution, Skeletal Muscle Mass and Ghrelin, Leptin Changes in T1D Patients.

Authors:  Dana Prídavková; Matej Samoš; Ivana Kazimierová; Ľudovít Šutarík; Soňa Fraňová; Peter Galajda; Marián Mokáň
Journal:  Obes Facts       Date:  2018-12-11       Impact factor: 3.942

2.  Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study.

Authors:  Aleksandra Cieluch; Aleksandra Uruska; Marcin Nowicki; Ewa Wysocka; Paweł Niedźwiecki; Agata Grzelka-Woźniak; Justyna Flotyńska; Dorota Zozulińska-Ziółkiewicz
Journal:  Arch Med Sci       Date:  2020-10-29       Impact factor: 3.707

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.